Bart Filius - Galapagos CFO

GLPG Stock  USD 32.20  0.75  2.28%   

CFO

Mr. Bart Filius has served as Chief Financial Officer of Galapagos NV since December 1, 2014. He has over 13 years experience at Sanofi. Since September 2017 he also has occupied the post of the Company Member of the Executive Committee, Chief Operating Officer. During the past three years as CFO Sanofi Europe, Bart was instrumental in transforming the Sanofi European organization to be well positioned beyond the patent cliff. Earlier at Sanofi, Bart was CFO and Country Manager of Sanofi in the Netherlands. Before that, he was Vice President for Mergers Acquisitions, during which time Bart led and completed the divestiture of various franchises. Prior to joining Sanofi, he was a strategy consultant at Arthur D. Little since 2017.
Tenure 7 years
Professional MarksMBA
Address Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800
Phone32 1 534 29 00
Webhttps://www.glpg.com
Bart Filius has an MBA degree from INSEAD and a bachelor’s degree in business from Nyenrode University.

Galapagos Management Efficiency

The company has return on total asset (ROA) of (0.0121) % which means that it has lost $0.0121 on every $100 spent on assets. This is way below average. Galapagos' management efficiency ratios could be used to measure how well Galapagos manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Capital Employed is estimated to decrease to -0.06. The current Return On Assets is estimated to decrease to -0.04. At this time, Galapagos' Total Current Assets are most likely to increase significantly in the upcoming years. The Galapagos' current Intangible Assets is estimated to increase to about 176.7 M, while Other Current Assets are projected to decrease to 1,710.
The company currently holds 21.9 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Galapagos NV ADR has a current ratio of 8.07, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Galapagos until it has trouble settling it off, either with new capital or with free cash flow. So, Galapagos' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Galapagos NV ADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Galapagos to invest in growth at high rates of return. When we think about Galapagos' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 5 records

CFO Age

James WatkinsBoot Barn Holdings
50
Kevin SierksVera Bradley
41
Robert MadoreRalph Lauren Corp
50
John BlackCanada Goose Holdings
57
Scott HurdAmerican Eagle Outfitters
46
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium. Galapagos operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1344 people. Galapagos NV ADR (GLPG) is traded on NASDAQ Exchange in USA. It is located in Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800 and employs 28 people. Galapagos is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Galapagos NV ADR Leadership Team

Elected by the shareholders, the Galapagos' board of directors comprises two types of representatives: Galapagos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Galapagos. The board's role is to monitor Galapagos' management team and ensure that shareholders' interests are well served. Galapagos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Galapagos' outside directors are responsible for providing unbiased perspectives on the board's policies.
Rajesh Parekh, Non-Executive Chairman of the Board
John Montana, Managing Argenta
Marieke Vermeersch, Head Communication
Ellen Aar, Head Development
Annelies Missotten, Chief Officer
Michele MBA, Head Commercial
Piet Wigerinck, Chief Scientific Officer
Chantal Tasset, Head Devel
Sofie Gijsel, Head Relations
Valeria Cnossen, General Counsel
Christine Mummery, Non-Executive Independent Director
Bart Filius, CFO
Onno Stolpe, Co-Founder, CEO, Managing Director and Executive Director
PharmD Raboisson, Head VP
Andre Hoekema, Sr. VP of Corporate Devel.
Katrine Bosley, Independent Non-Executive Director
Walid AbiSaab, Member of the Executive Committee, Chief Medical Officer
Howard Rowe, Non-Executive Independent Director
Dirk Naeyer, Head Operations
Alice Dietrich, Head Affairs
Harrold Barlingen, Non-Executive Director
Philippe Alen, Senior Development
Elizabeth Goodwin, VP Corporate Communications & Investor Relations
Mary Kerr, Non-Executive Independent Director
Thad Huston, CFO COO
MBA MBA, COO Pres
Werner Cautreels, Non-Executive Independent Director

Galapagos Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Galapagos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Galapagos NV ADR is a strong investment it is important to analyze Galapagos' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Galapagos' future performance. For an informed investment choice regarding Galapagos Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galapagos NV ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Galapagos Stock analysis

When running Galapagos' price analysis, check to measure Galapagos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galapagos is operating at the current time. Most of Galapagos' value examination focuses on studying past and present price action to predict the probability of Galapagos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galapagos' price. Additionally, you may evaluate how the addition of Galapagos to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Global Correlations
Find global opportunities by holding instruments from different markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Is Galapagos' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Galapagos. If investors know Galapagos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Galapagos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.19
Earnings Share
(2.54)
Revenue Per Share
0.1818
Quarterly Revenue Growth
(0.12)
Return On Assets
(0.01)
The market value of Galapagos NV ADR is measured differently than its book value, which is the value of Galapagos that is recorded on the company's balance sheet. Investors also form their own opinion of Galapagos' value that differs from its market value or its book value, called intrinsic value, which is Galapagos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Galapagos' market value can be influenced by many factors that don't directly affect Galapagos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Galapagos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Galapagos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galapagos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.